Cargando…

Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease

OBJECTIVES: The objectives of this study were to present procedure- and device-associated adverse events (AEs) identified with long-term drug delivery via percutaneous endoscopic gastrojejunostomy (PEG-J). Levodopa-carbidopa intestinal gel (LCIG, also known in US as carbidopa-levodopa enteral suspen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Epstein, Michael, Johnson, David A, Hawes, Robert, Schmulewitz, Nathan, Vanagunas, Arvydas D, Gossen, E Roderich, Robieson, Weining Z, Eaton, Susan, Dubow, Jordan, Chatamra, Krai, Benesh, Janet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822096/ https://www.ncbi.nlm.nih.gov/pubmed/27030949 http://dx.doi.org/10.1038/ctg.2016.19

Ejemplares similares

Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease
por: Fernandez, Hubert H, et al.
Publicado: (2016)

Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients
por: Murata, Miho, et al.
Publicado: (2016)

Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease
por: Murata, Miho, et al.
Publicado: (2018)

Reply to letter: Suicide in Parkinson's disease patients treated with levodopa‐carbidopa Intestinal Gel
por: Fernandez, Hubert H., et al.
Publicado: (2015)

Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
por: Lang, Anthony E., et al.
Publicado: (2015)

Effect of levodopa‐carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
por: Antonini, Angelo, et al.
Publicado: (2016)

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson'd Disease: Final 12-Month, Open-Label Results
por: Fernandez, Hubert H, et al.
Publicado: (2015)

Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics
por: Standaert, David G., et al.
Publicado: (2018)

Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
por: Othman, Ahmed A., et al.
Publicado: (2015)

Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease
por: Standaert, David G., et al.
Publicado: (2017)

PEG J tube placement with optimization of J tube insertion
por: Roberto Simons-Linares, C., et al.
Publicado: (2020)

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa
por: Zadikoff, Cindy, et al.
Publicado: (2020)

A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies
por: Boyd, James T., et al.
Publicado: (2019)

Increased Prevalence of Polyneuropathy in Parkinson’s Disease Patients: An Observational Study
por: Conradt, Christian, et al.
Publicado: (2018)

Implementing Levodopa‐Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners
por: Burack, Michelle, et al.
Publicado: (2018)

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
por: Waring, Jeffrey F., et al.
Publicado: (2015)

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
por: Othman, Ahmed A., et al.
Publicado: (2017)

PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
por: Simoni, Simone, et al.
Publicado: (2022)

Follow Up After PEG Tube Insertion
por: Gallagher, Herbert
Publicado: (2007)

Follow Up After PEG Tube Insertion
por: McGivern, Margaret
Publicado: (2007)

Missing PEG tube found at the ileocecal valve
por: Kondaveety, Soumya, et al.
Publicado: (2021)

Modified reference based imputation and tipping point analysis in the presence of missing data due to COVID-19
por: Jin, Man, et al.
Publicado: (2021)

Obstructive Acute Pancreatitis Secondary to PEG Tube Migration
por: Taylor, Douglas F., et al.
Publicado: (2016)

Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson’s Disease Treatment
por: Nomoto, Yusuke, et al.
Publicado: (2023)

The impact of tube replacement timing during LCIG therapy on PEG-J associated adverse events: a retrospective multicenter observational study
por: Yamashita, Kanefumi, et al.
Publicado: (2021)

Properties of small molecular drug loading and diffusion in a fluorinated PEG hydrogel studied by (1)H molecular diffusion NMR and (19)F spin diffusion NMR
por: Mathias, Errol V., et al.
Publicado: (2010)

Who follows up patients after PEG tube insertion?
por: Lowry, Sharon, et al.
Publicado: (2007)

Risks of PEG tube placement in patients with cirrhosis-associated ascites
por: Al-Abboodi, Yasir, et al.
Publicado: (2017)

Transcolonic misplacement as a rare complication associated with PEG tube
por: Kozyk, Marko, et al.
Publicado: (2022)

Clinical Reports: Letter from Dr. E. J. Beall
por: Beall, E. J.
Publicado: (1893)

Report of a Case of Membranous Croup Successfully Treated with O’Dwyer’s Tubes
por: Kenney, Jno. W.
Publicado: (1898)

Enlargement of Lymphatic Glands about the Bifurcation of the Trachea and Bronchial Tubes, Obstructing Respiration
por: Cushing, C.
Publicado: (1866)

Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry
por: Poewe, Werner, et al.
Publicado: (2020)

Oral language skills, callous and unemotional traits and high-risk patterns of youth offending
por: Anderson, Stavroola A. S., et al.
Publicado: (2022)

Abscess in the Testicle
por: Eaton, M. M.
Publicado: (1866)

Pelvic Abscess
por: Eaton, Morton M.
Publicado: (1867)

Suspended Development in Twin Pregnancies
por: Eaton, M. M.
Publicado: (1867)

Paralysis of One Leg Caused by Retroversion of the Uterus
por: Eaton, M. M.
Publicado: (1868)

Four and A-Half Inches of Whalebone in the Uterus: Abortion.—Narrow Escape from Death
por: Eaton, M. M.
Publicado: (1868)

Nitrate of Silver in the Treatment of Uterine Polypi
por: Eaton, M. M.
Publicado: (1868)

Cannot write session to /tmp/vufind_sessions/sess_0oi3bjta2iiinc12gom3o80odq